MedTech Innovator

TrackX Technology specializes in developing advanced imaging guidance systems that enhance the safety and effectiveness of minimally invasive spine procedures. The company's technology offers real-time tracking of surgical instruments and implants, utilizing pseudo-live fluoroscopy to ensure precise positioning while significantly reducing radiation exposure for patients and medical staff. By focusing on procedurally driven imaging solutions, TrackX aims to improve surgical outcomes and operational efficiency within the operating room.

Phiex Technologies specializes in the development of innovative interactive materials aimed at enhancing efficiency and cost-effectiveness in various sectors, including medical device manufacturing and food safety. The company focuses on creating self-sterilizing packaging materials that eliminate the need for traditional sterilization methods, such as ethylene oxide, which are associated with health risks. These advanced materials allow for the manufacturing of sterile medical devices without the requirement for pre-conditioning, such as humidity, heat, or pressure, thereby streamlining the production process. By providing a solution that replaces third-party sterilizers, Phiex Technologies aims to improve safety and sustainability in the packaging industry.

Leadoptik is a deep-tech company focused on developing advanced miniature imaging technology designed for minimally invasive medical procedures. Its platform enhances surgical capabilities by providing high-resolution imaging and 3D navigation in real time, allowing surgeons to visualize small anatomical structures with greater clarity than existing imaging systems. This innovative approach facilitates the early detection of cancer and improves the overall effectiveness of surgical interventions, ultimately contributing to better patient outcomes.

Altratech Limited designs biosensors and semiconductor chips for DNA testing of food traceability for agri business. The company was incorporated in 2013 and is based in Shannon, Ireland.

toSense, Inc. is a healthcare technology company based in San Diego, California, focused on developing innovative solutions for at-home monitoring of chronic illnesses, particularly for patients with conditions such as congestive heart failure and chronic obstructive pulmonary disease. The company's flagship product, the CoVa Monitoring System, is a wearable sensor designed to monitor various health parameters, including thoracic impedance, heart rate, and respiration rate. This device, worn as a necklace and secured with disposable electrodes, transmits vital signs to gateways that relay the data to a web-based system for clinical review. This technology allows healthcare providers to detect potential issues earlier than traditional monitoring methods, enabling timely intervention. Established in 2008 and formerly known as Perminova, Inc., toSense operates as a subsidiary of Baxter International Inc. and aims to address pressing medical challenges through its hardware and software solutions.

Advanced Chemotherapy Technologies is a healthcare company that is developing breakthrough combination drug-device technologies for treating pancreatic cancer.

2C Tech specializes in the development of innovative therapeutic approaches for ophthalmic diseases, utilizing advanced nanoparticle and Quantum Dot technologies. The company aims to address unmet medical needs in patients suffering from retinal degenerative conditions, with a primary focus on creating a proprietary therapy for Retinitis Pigmentosa. In addition to Retinitis Pigmentosa, 2C Tech's technology has the potential to benefit patients with other serious conditions such as Macular Degeneration, Glaucoma, and Diabetic Retinopathy, which affect a larger population. By leveraging its unique expertise, 2C Tech strives to provide effective treatment options that can significantly improve patient outcomes in the field of ocular medicine.

NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,